Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UConn Partners with KeraFAST

Published: Wednesday, February 26, 2014
Last Updated: Wednesday, February 26, 2014
Bookmark and Share
The University of Connecticut have signed an agreement with KeraFAST to market stem cells to investigators studying genetic disorders around the world.

The partnership with KeraFAST will ease the way for other institutions to obtain the cell lines, resulting in more widespread use in the research community, according to Marc Lalande, executive director of Genomics and Personalized Medicine Programs at UConn, and director for both the UConn Stem Cell Institute and the Institute for Systems Genomics.

KeraFAST offers an array of biological materials and scientific tools to academic, government, and industry research laboratories worldwide. The company handles requests between institutions and speeds up the licensing process. UConn’s stem cell lines are the first the company is marketing, says Lalande.

Already, a number of prominent institutions, such as the University of Cambridge, the National Cancer Institute, the Salk Institute and the University of California-Davis, have requested the UConn stem cells for research and drug discovery.

“The potential for producing targeted therapies from stem cells to treat disease and repair or regenerate tissues and organs defines the future of personalized medicine,” Lalande says.

The two UConn stem cell lines, created in 2009 by researchers in the Department of Genetics and Developmental Biology, were generated from skin cells taken from patients with deletions of sections of chromosome 15 who develop Angelman Syndrome, and Prader-Willi Syndrome,  two relatively rare, neurogenetic disorders.

The agreement with KeraFAST, says Lalande, is “a testament that cell lines developed by our team are a valuable research tool for biomedical scientists around the world to test new hypotheses and compare findings in standardized stem cell models for drug discovery and other applications.”

Researchers use stem cells to learn how different patients might respond to new drugs in the early stages of development.

Says Lalande, “The aim is to make UConn’s lines available to broaden the research base into more common disorders such as autism and schizophrenia.”



Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!